Named Patient Supply (Compassionate Use)

Bronchitol®

Pharmaxis is collaborating with distribution partners around the world to provide Bronchitol® (inhaled dry powder mannitol) via named patient supply to people suffering from Cystic Fibrosis.

What is named patient supply?

Named patient supply is a mechanism that permits the supply of an unlicensed product to a specific healthcare professional for the treatment of an individual patient. Each country has its own regulations that provide a mechanism to allow access to patients who need these medicinal products. The exact requirements for use vary from country to country.

How can I obtain Bronchitol?

 

For Australia, New Zealand or USA:

Healthcare professionals in Australia, New Zealand or USA may contact Pharmaxis for further information about access to Bronchitol for named patient use:

Pharmaxis Medical Information
Phone: +44 1628 902 053
Email: med.info@pharmaxis.com.au

 

For the Rest of the World:

Healthcare professionals from the rest of the world may also be able to obtain Bronchitol via named patient supply. For further information please contact:

Clinigen Pharma Limited, UK

Tel: +44 (0) 1283 494 340

Fax: +44 (0) 1283 494 341

Email: customer.services@clinigengroup.com

Please note that Pharmaxis are not able to provide advice on the suitability of Bronchitol for individual patients. Patients wishing to know more about Bronchitol should discuss with their doctor the most suitable treatment for them.